This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Manitoba directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $200,000
Evaluation of IFN-lambda as a novel antiviral therapeutic for genital HPV and HSV-2 infection in vivo
CIHR · 2024 · Principal investigator
Evaluation of IFN-lambda as a novel antiviral therapeutic for genital HPV and HSV-2 infection in vivo
Principal investigators: Murooka, Thomas T; Ashkar, Ali A; Santer, Deanna
Keywords: Female Genital Tract; Herpes Simplex Virus (Hsv); Human Papillomavirus (Hpv); Immune Activation; Inflammation; Innate Immunity; Interferon-Lambda; Mouse Models Of Infection; Vaginal Epithelial Barrier; Virus Replication
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.